speb/financial-data huggingface dataset:
MET balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 76000000.00
MET balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -22621000000.00
MET income_statement (annual, 2022-12-31) — Other Gand A: 669000000.00
MET income_statement (annual, 2022-12-31) — Other Income Expense: 520000000.00
MET cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3724000000.00
MET income_statement (annual, 2022-12-31) — Other Operating Expenses: 751000000.00
MET balance_sheet (annual, 2022-12-31) — Other Payable: 20937000000.00
MET balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 281715000000.00
MET balance_sheet (annual, 2022-12-31) — Payables: 387000000.00
MET balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 387000000.00
MET income_statement (annual, 2022-12-31) — Policyholder Benefits Ceded: 2386000000.00
MET income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: 48333000000.00
MET balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 24072200.00
MET balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
MET cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -185000000.00
MET income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 185000000.00
MET cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
MET cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
MET income_statement (annual, 2022-12-31) — Pretax Income: 6364000000.00
MET cash_flow (annual, 2022-12-31) — Purchase Of Business: -2914000000.00
MET cash_flow (annual, 2022-12-31) — Purchase Of Investment: -104644000000.00
MET cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -1208000000.00
MET balance_sheet (annual, 2022-12-31) — Receivables: 18724000000.00
MET income_statement (annual, 2022-12-31) — Reconciled Depreciation: 673000000.00
MET cash_flow (annual, 2022-12-31) — Repayment Of Debt: -85000000.00
MET cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3326000000.00
MET income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -41000000.00
MET balance_sheet (annual, 2022-12-31) — Retained Earnings: 40332000000.00
MET income_statement (annual, 2022-12-31) — Salaries And Wages: 5191000000.00
MET cash_flow (annual, 2022-12-31) — Sale Of Business: 2205000000.00
MET cash_flow (annual, 2022-12-31) — Sale Of Investment: 108428000000.00
MET cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 1096000000.00
MET income_statement (annual, 2022-12-31) — Selling General And Administration: 5860000000.00
MET balance_sheet (annual, 2022-12-31) — Share Issued: 1189831471.00
MET income_statement (annual, 2022-12-31) — Special Income Charges: 41000000.00
MET balance_sheet (annual, 2022-12-31) — Stockholders Equity: 29881000000.00
MET balance_sheet (annual, 2022-12-31) — Tangible Book Value: 20584000000.00
MET income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
MET income_statement (annual, 2022-12-31) — Tax Provision: 1062000000.00
MET income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.17
MET balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1360000000.00
MET balance_sheet (annual, 2022-12-31) — Total Assets: 663072000000.00
MET balance_sheet (annual, 2022-12-31) — Total Capitalization: 47630000000.00
MET balance_sheet (annual, 2022-12-31) — Total Debt: 17980000000.00
MET balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 30125000000.00
MET income_statement (annual, 2022-12-31) — Total Expenses: 61045000000.00
MET balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 632947000000.00
MET income_statement (annual, 2022-12-31) — Total Unusual Items: 41000000.00
MET income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 41000000.00
MET balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 410733057.00
MET balance_sheet (annual, 2022-12-31) — Treasury Stock: 21458000000.00
MET income_statement (annual, 2023-12-31) — +Total Revenue: 67934000000.00
MET balance_sheet (annual, 2023-12-31) — Accounts Receivable: 28971000000.00
MET balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 33690000000.00
MET cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1332000000.00
MET income_statement (annual, 2023-12-31) — Basic Average Shares: 762430939.00
MET income_statement (annual, 2023-12-31) — Basic EPS: 1.81
MET cash_flow (annual, 2023-12-31) — Beginning Cash Position: 20195000000.00
MET balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 32000000.00
MET balance_sheet (annual, 2023-12-31) — Capital Stock: 12000000.00
MET balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 20639000000.00
MET balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 308096000000.00
MET cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1764000000.00
MET cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -2940000000.00
MET cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -10246000000.00
MET cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 13721000000.00
MET cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -663000000.00
MET cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 2115000000.00
MET cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1835000000.00
MET cash_flow (annual, 2023-12-31) — Change In Receivables: -1952000000.00
MET cash_flow (annual, 2023-12-31) — Change In Working Capital: 1448000000.00
MET cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1952000000.00
MET cash_flow (annual, 2023-12-31) — Changes In Cash: 535000000.00
MET balance_sheet (annual, 2023-12-31) — Commercial Paper: 0.00
MET balance_sheet (annual, 2023-12-31) — Common Stock: 12000000.00
MET cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -1566000000.00
MET balance_sheet (annual, 2023-12-31) — Common Stock Equity: 30015000000.00
MET cash_flow (annual, 2023-12-31) — Common Stock Payments: -3103000000.00
MET balance_sheet (annual, 2023-12-31) — Current Debt: 119000000.00
MET balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 119000000.00
MET cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 718000000.00
MET income_statement (annual, 2023-12-31) — Diluted Average Shares: 762430939.00
MET income_statement (annual, 2023-12-31) — Diluted EPS: 1.81
MET income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 1380000000.00
MET balance_sheet (annual, 2023-12-31) — Dividends Payable: 386000000.00
MET income_statement (annual, 2023-12-31) — EBIT: 3207000000.00
MET cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 1090000000.00
MET cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -91000000.00
MET cash_flow (annual, 2023-12-31) — End Cash Position: 20639000000.00
MET cash_flow (annual, 2023-12-31) — Financing Cash Flow: -2940000000.00
MET cash_flow (annual, 2023-12-31) — Free Cash Flow: 13721000000.00
MET cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 2800000000.00
MET balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -19242000000.00
MET income_statement (annual, 2023-12-31) — General And Administrative Expense: 6177000000.00
MET balance_sheet (annual, 2023-12-31) — Goodwill: 9236000000.00
MET balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 9236000000.00
MET cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1833000000.00
MET income_statement (annual, 2023-12-31) — Interest Expense: 1045000000.00
MET income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1045000000.00
MET cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 989000000.00
MET balance_sheet (annual, 2023-12-31) — Invested Capital: 48811000000.00
MET cash_flow (annual, 2023-12-31) — Investing Cash Flow: -10246000000.00
MET balance_sheet (annual, 2023-12-31) — Investments And Advances: 315165000000.00
MET balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 15906000000.00
MET cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2671000000.00
MET balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 32000000.00
MET balance_sheet (annual, 2023-12-31) — Long Term Debt: 18677000000.00
MET balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 18709000000.00
MET cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2671000000.00
MET cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1880000000.00
MET balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 15906000000.00
MET income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 43551000000.00
MET balance_sheet (annual, 2023-12-31) — Minority Interest: 238000000.00
MET income_statement (annual, 2023-12-31) — Minority Interests: -24000000.00
MET cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -755000000.00
MET cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -3103000000.00
MET income_statement (annual, 2023-12-31) — Net Income: 1578000000.00
MET income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 1380000000.00
MET income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1602000000.00
MET income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 1578000000.00
MET income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 1578000000.00
MET cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1602000000.00
MET income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1602000000.00
MET income_statement (annual, 2023-12-31) — Net Interest Income: -1045000000.00
MET cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -914000000.00
MET cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -8178000000.00
MET cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 791000000.00
MET cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 791000000.00
MET income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1045000000.00
MET cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 4419000000.00
MET cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -143000000.00
MET balance_sheet (annual, 2023-12-31) — Net PPE: 1993000000.00
MET income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 43551000000.00
MET cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
MET balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 20779000000.00
MET balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 927000000.00
MET balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 927000000.00
MET income_statement (annual, 2023-12-31) — Normalized Income: 1578000000.00
MET cash_flow (annual, 2023-12-31) — Operating Cash Flow: 13721000000.00
MET cash_flow (annual, 2023-12-31) — Operating Gains Losses: 3890000000.00
MET income_statement (annual, 2023-12-31) — Operating Revenue: 67934000000.00
MET balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 730821111.00
MET balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 119000000.00
MET balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -19242000000.00
MET income_statement (annual, 2023-12-31) — Other Gand A: 828000000.00
MET income_statement (annual, 2023-12-31) — Other Income Expense: 545000000.00
MET cash_flow (annual, 2023-12-31) — Other Non Cash Items: -3834000000.00
MET income_statement (annual, 2023-12-31) — Other Operating Expenses: 1962000000.00
MET balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 287457000000.00
MET balance_sheet (annual, 2023-12-31) — Payables: 386000000.00
MET balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 386000000.00
MET income_statement (annual, 2023-12-31) — Policyholder Benefits Ceded: 2435000000.00
MET income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 46020000000.00
MET balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 96200000.00
MET balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
MET cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -198000000.00
MET income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 198000000.00
MET cash_flow (annual, 2023-12-31) — Preferred Stock Payments: 0.00
MET income_statement (annual, 2023-12-31) — Pretax Income: 2162000000.00
MET cash_flow (annual, 2023-12-31) — Purchase Of Business: -1670000000.00
MET cash_flow (annual, 2023-12-31) — Purchase Of Investment: -84274000000.00
MET cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -1057000000.00
MET balance_sheet (annual, 2023-12-31) — Receivables: 30195000000.00
MET income_statement (annual, 2023-12-31) — Reconciled Depreciation: 718000000.00
MET cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1880000000.00
MET cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -3103000000.00
MET balance_sheet (annual, 2023-12-31) — Retained Earnings: 40146000000.00
MET income_statement (annual, 2023-12-31) — Salaries And Wages: 5349000000.00
MET cash_flow (annual, 2023-12-31) — Sale Of Business: 915000000.00
MET cash_flow (annual, 2023-12-31) — Sale Of Investment: 76096000000.00
MET cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 143000000.00
MET income_statement (annual, 2023-12-31) — Selling General And Administration: 6177000000.00
MET balance_sheet (annual, 2023-12-31) — Share Issued: 1191823651.00
MET balance_sheet (annual, 2023-12-31) — Stockholders Equity: 30015000000.00
MET balance_sheet (annual, 2023-12-31) — Tangible Book Value: 20779000000.00
MET income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MET income_statement (annual, 2023-12-31) — Tax Provision: 560000000.00
MET income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
MET balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1224000000.00
MET balance_sheet (annual, 2023-12-31) — Total Assets: 687584000000.00
MET balance_sheet (annual, 2023-12-31) — Total Capitalization: 48692000000.00
MET balance_sheet (annual, 2023-12-31) — Total Debt: 18828000000.00
MET balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 30253000000.00
MET income_statement (annual, 2023-12-31) — Total Expenses: 65772000000.00
MET balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 657331000000.00
MET balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 461002540.00
MET balance_sheet (annual, 2023-12-31) — Treasury Stock: 24591000000.00
MET income_statement (annual, 2024-12-31) — +Total Revenue: 70131000000.00
MET balance_sheet (annual, 2024-12-31) — Accounts Receivable: 29761000000.00
MET balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 33791000000.00
MET cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1512000000.00
MET income_statement (annual, 2024-12-31) — Basic Average Shares: 689211065.00
MET income_statement (annual, 2024-12-31) — Basic EPS: 6.13
MET cash_flow (annual, 2024-12-31) — Beginning Cash Position: 20639000000.00
MET balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 6000000.00
MET balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 6000000.00
MET balance_sheet (annual, 2024-12-31) — Capital Stock: 12000000.00
MET balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 20068000000.00
MET balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 306267000000.00
MET cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1727000000.00
MET cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -3131000000.00
MET cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -11493000000.00
MET cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 14598000000.00
MET cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -518000000.00
MET cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -580000000.00
MET cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1266000000.00
MET cash_flow (annual, 2024-12-31) — Change In Receivables: 460000000.00
MET cash_flow (annual, 2024-12-31) — Change In Working Capital: 1366000000.00
MET cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 460000000.00
MET cash_flow (annual, 2024-12-31) — Changes In Cash: -26000000.00
MET balance_sheet (annual, 2024-12-31) — Common Stock: 12000000.00
MET cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -1527000000.00
MET balance_sheet (annual, 2024-12-31) — Common Stock Equity: 27445000000.00
MET cash_flow (annual, 2024-12-31) — Common Stock Payments: -3207000000.00
MET balance_sheet (annual, 2024-12-31) — Current Debt: 465000000.00
MET balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 465000000.00
MET balance_sheet (annual, 2024-12-31) — Current Notes Payable: 0.00
MET balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 0.00
MET cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 714000000.00
MET income_statement (annual, 2024-12-31) — Diluted Average Shares: 689211065.00
MET income_statement (annual, 2024-12-31) — Diluted EPS: 6.13
MET income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 4226000000.00
MET balance_sheet (annual, 2024-12-31) — Dividends Payable: 385000000.00
MET income_statement (annual, 2024-12-31) — EBIT: 6659000000.00
MET cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 844000000.00
MET cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -545000000.00
MET cash_flow (annual, 2024-12-31) — End Cash Position: 20068000000.00
MET cash_flow (annual, 2024-12-31) — Financing Cash Flow: -3131000000.00
MET cash_flow (annual, 2024-12-31) — Free Cash Flow: 14598000000.00
MET cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1165000000.00
MET balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -21186000000.00
MET income_statement (annual, 2024-12-31) — General And Administrative Expense: 5991000000.00
MET balance_sheet (annual, 2024-12-31) — Goodwill: 8901000000.00
MET balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 8901000000.00
MET cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1600000000.00
MET income_statement (annual, 2024-12-31) — Interest Expense: 1037000000.00
MET income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1037000000.00
MET cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1037000000.00
MET balance_sheet (annual, 2024-12-31) — Invested Capital: 46154000000.00
MET cash_flow (annual, 2024-12-31) — Investing Cash Flow: -11493000000.00
MET balance_sheet (annual, 2024-12-31) — Investments And Advances: 314666000000.00
MET balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 16384000000.00
MET cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1853000000.00
MET balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 6000000.00
MET balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 6000000.00
MET balance_sheet (annual, 2024-12-31) — Long Term Debt: 18244000000.00
MET balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 18250000000.00
MET cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1853000000.00
MET cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2674000000.00
MET balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 16384000000.00
MET income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 43413000000.00
MET balance_sheet (annual, 2024-12-31) — Minority Interest: 258000000.00
MET income_statement (annual, 2024-12-31) — Minority Interests: -18000000.00
MET cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -358000000.00
MET cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -3207000000.00
MET income_statement (annual, 2024-12-31) — Net Income: 4426000000.00
MET income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 4226000000.00
MET income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4444000000.00
MET income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4426000000.00
MET income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4426000000.00
MET cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 4444000000.00
MET income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4444000000.00
MET income_statement (annual, 2024-12-31) — Net Interest Income: -1037000000.00
MET cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -280000000.00
MET cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -12201000000.00
MET cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -821000000.00
MET cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -821000000.00
MET income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1037000000.00
MET cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 2868000000.00
MET cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -173000000.00
MET balance_sheet (annual, 2024-12-31) — Net PPE: 1851000000.00
MET income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 43413000000.00
MET cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
MET balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 18544000000.00
MET balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 132000000.00
MET balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 132000000.00
MET income_statement (annual, 2024-12-31) — Normalized Income: 4426000000.00
MET cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14598000000.00
MET cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2009000000.00
MET income_statement (annual, 2024-12-31) — Operating Revenue: 70131000000.00
MET balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 689211065.00
MET balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 465000000.00
MET balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -21186000000.00
MET income_statement (annual, 2024-12-31) — Other Gand A: 481000000.00
MET income_statement (annual, 2024-12-31) — Other Income Expense: 627000000.00
MET cash_flow (annual, 2024-12-31) — Other Non Cash Items: -3623000000.00
MET income_statement (annual, 2024-12-31) — Other Operating Expenses: 825000000.00
MET balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 286199000000.00
MET balance_sheet (annual, 2024-12-31) — Payables: 385000000.00
MET balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 385000000.00
MET income_statement (annual, 2024-12-31) — Policyholder Benefits Ceded: 4566000000.00
MET income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 47979000000.00
MET balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 96200000.00
MET balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
MET cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -200000000.00
MET income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 200000000.00
MET cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
MET income_statement (annual, 2024-12-31) — Pretax Income: 5622000000.00
MET cash_flow (annual, 2024-12-31) — Purchase Of Business: -1441000000.00
MET cash_flow (annual, 2024-12-31) — Purchase Of Investment: -82138000000.00
MET cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -1033000000.00
MET balance_sheet (annual, 2024-12-31) — Receivables: 30770000000.00
MET income_statement (annual, 2024-12-31) — Reconciled Depreciation: 714000000.00
MET cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2674000000.00
MET cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -3207000000.00
MET balance_sheet (annual, 2024-12-31) — Retained Earnings: 42626000000.00
MET income_statement (annual, 2024-12-31) — Salaries And Wages: 5510000000.00
MET cash_flow (annual, 2024-12-31) — Sale Of Business: 1083000000.00
MET cash_flow (annual, 2024-12-31) — Sale Of Investment: 69937000000.00
MET cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 753000000.00
MET income_statement (annual, 2024-12-31) — Selling General And Administration: 5991000000.00
MET balance_sheet (annual, 2024-12-31) — Share Issued: 1194168628.00
MET balance_sheet (annual, 2024-12-31) — Stockholders Equity: 27445000000.00
MET balance_sheet (annual, 2024-12-31) — Tangible Book Value: 18544000000.00
MET income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MET income_statement (annual, 2024-12-31) — Tax Provision: 1178000000.00
MET income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
MET balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1009000000.00
MET balance_sheet (annual, 2024-12-31) — Total Assets: 677457000000.00
MET balance_sheet (annual, 2024-12-31) — Total Capitalization: 45689000000.00
MET balance_sheet (annual, 2024-12-31) — Total Debt: 18715000000.00
MET balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 27703000000.00
MET income_statement (annual, 2024-12-31) — Total Expenses: 64509000000.00
MET balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 649754000000.00
MET balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 504957563.00
MET balance_sheet (annual, 2024-12-31) — Treasury Stock: 27798000000.00
MET income_statement (quarterly, 2025-03-31) — +Total Revenue: 18288000000.00
MET balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 31251000000.00
MET balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 33820000000.00
MET income_statement (quarterly, 2025-03-31) — Basic Average Shares: 682300000.00
MET income_statement (quarterly, 2025-03-31) — Basic EPS: 1.29
MET cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 20068000000.00
MET balance_sheet (quarterly, 2025-03-31) — Capital Stock: 12000000.00
MET balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 21326000000.00
MET balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 109125000000.00
MET cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -440000000.00
MET cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 220000000.00
MET cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3322000000.00
MET cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1160000000.00
MET balance_sheet (quarterly, 2025-03-31) — Common Stock: 12000000.00
MET cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -374000000.00
MET balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 27493000000.00
MET cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1411000000.00
MET balance_sheet (quarterly, 2025-03-31) — Current Debt: 381000000.00
MET balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 381000000.00
MET income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 687000000.00
MET income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.28
MET income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 879000000.00
MET balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 356000000.00
MET income_statement (quarterly, 2025-03-31) — EBIT: 1612000000.00
MET cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 98000000.00
MET cash_flow (quarterly, 2025-03-31) — End Cash Position: 21326000000.00
MET cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 220000000.00
MET cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 4262000000.00
MET balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -20248000000.00
MET income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1563000000.00
MET balance_sheet (quarterly, 2025-03-31) — Goodwill: 9036000000.00
MET balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 9036000000.00
MET cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 147000000.00
MET income_statement (quarterly, 2025-03-31) — Interest Expense: 258000000.00
MET income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 258000000.00
MET cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 224000000.00
MET balance_sheet (quarterly, 2025-03-31) — Invested Capital: 46722000000.00
MET cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3322000000.00
MET balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 324334000000.00
MET balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 14885000000.00
MET cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1155000000.00
MET balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 18848000000.00
MET balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 18848000000.00
MET cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1155000000.00
MET cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -810000000.00
MET balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 14885000000.00
MET income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 12074000000.00
MET balance_sheet (quarterly, 2025-03-31) — Minority Interest: 262000000.00
MET income_statement (quarterly, 2025-03-31) — Minority Interests: -5000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 23000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1411000000.00
MET income_statement (quarterly, 2025-03-31) — Net Income: 945000000.00
MET income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 879000000.00
MET income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 950000000.00
MET income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 945000000.00
MET income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 945000000.00
MET income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 950000000.00
MET income_statement (quarterly, 2025-03-31) — Net Interest Income: -258000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -66000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -4376000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 345000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 345000000.00
MET income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -258000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 1493000000.00
MET cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -51000000.00
MET balance_sheet (quarterly, 2025-03-31) — Net PPE: 1846000000.00
MET income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 12074000000.00
MET balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 18457000000.00
MET balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 430000000.00
MET balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 430000000.00
MET income_statement (quarterly, 2025-03-31) — Normalized Income: 945000000.00
MET cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 4262000000.00
MET income_statement (quarterly, 2025-03-31) — Operating Revenue: 18288000000.00
MET balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 673293988.00
MET balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 381000000.00
MET balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -20248000000.00
MET income_statement (quarterly, 2025-03-31) — Other Gand A: 126000000.00
MET income_statement (quarterly, 2025-03-31) — Other Income Expense: 76000000.00
MET income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 140000000.00
MET balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 87799000000.00
MET balance_sheet (quarterly, 2025-03-31) — Payables: 356000000.00
MET balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 356000000.00
MET income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 12074000000.00
MET balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 64032200.00
MET balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
MET cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -66000000.00
MET income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 66000000.00
MET income_statement (quarterly, 2025-03-31) — Pretax Income: 1354000000.00
MET cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -278000000.00
MET cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -23850000000.00
MET cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -114000000.00
MET balance_sheet (quarterly, 2025-03-31) — Receivables: 32277000000.00
MET cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -810000000.00
MET cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1411000000.00
MET balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 43131000000.00
MET income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1437000000.00
MET cash_flow (quarterly, 2025-03-31) — Sale Of Business: 301000000.00
MET cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 19474000000.00
MET cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 48000000.00
MET income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1563000000.00
MET balance_sheet (quarterly, 2025-03-31) — Share Issued: 1195220577.00
MET balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 27493000000.00
MET balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 18457000000.00
MET income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MET income_statement (quarterly, 2025-03-31) — Tax Provision: 404000000.00
MET income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
MET balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 1026000000.00
MET balance_sheet (quarterly, 2025-03-31) — Total Assets: 688316000000.00
MET balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 46341000000.00
MET balance_sheet (quarterly, 2025-03-31) — Total Debt: 19229000000.00
MET balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 27755000000.00
MET income_statement (quarterly, 2025-03-31) — Total Expenses: 16909000000.00
MET balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 660561000000.00
MET balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 521926589.00
MET balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 29222000000.00
MET income_statement (quarterly, 2025-06-30) — +Total Revenue: 17176000000.00
MET balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 31503000000.00
MET balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 33822000000.00
MET income_statement (quarterly, 2025-06-30) — Basic Average Shares: 670800000.00
MET income_statement (quarterly, 2025-06-30) — Basic EPS: 1.04
MET cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 21326000000.00
MET balance_sheet (quarterly, 2025-06-30) — Capital Stock: 12000000.00
MET balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 22178000000.00
MET balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 112685000000.00
MET cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -413000000.00
MET cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1449000000.00
MET cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2981000000.00
MET cash_flow (quarterly, 2025-06-30) — Changes In Cash: 655000000.00
MET balance_sheet (quarterly, 2025-06-30) — Common Stock: 12000000.00
MET cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -382000000.00
MET balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 27685000000.00
MET cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -510000000.00
MET balance_sheet (quarterly, 2025-06-30) — Current Debt: 379000000.00
MET balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 379000000.00
MET income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 675000000.00
MET income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.03
MET income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 698000000.00
MET balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 367000000.00
MET income_statement (quarterly, 2025-06-30) — EBIT: 1249000000.00
MET cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 197000000.00
MET cash_flow (quarterly, 2025-06-30) — End Cash Position: 22178000000.00
MET cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1449000000.00
MET cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2187000000.00
MET balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -19859000000.00
MET income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1545000000.00
MET balance_sheet (quarterly, 2025-06-30) — Goodwill: 9142000000.00
MET balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 9142000000.00
MET cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 783000000.00
MET income_statement (quarterly, 2025-06-30) — Interest Expense: 269000000.00
MET income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 269000000.00
MET cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 283000000.00
MET balance_sheet (quarterly, 2025-06-30) — Invested Capital: 47591000000.00
MET cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2981000000.00
MET balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 332214000000.00
MET balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 14993000000.00
MET cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 892000000.00
MET balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 19527000000.00
MET balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 19527000000.00
MET cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 892000000.00
MET cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -420000000.00
MET balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 14993000000.00
MET income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 10495000000.00
MET balance_sheet (quarterly, 2025-06-30) — Minority Interest: 242000000.00
MET income_statement (quarterly, 2025-06-30) — Minority Interests: -6000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -169000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -510000000.00
MET income_statement (quarterly, 2025-06-30) — Net Income: 729000000.00
MET income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 698000000.00
MET income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 735000000.00
MET income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 729000000.00
MET income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 729000000.00
MET income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 735000000.00
MET income_statement (quarterly, 2025-06-30) — Net Interest Income: -269000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -249000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -3569000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 472000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 472000000.00
MET income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -269000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 2251000000.00
MET cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -23000000.00
MET balance_sheet (quarterly, 2025-06-30) — Net PPE: 1825000000.00
MET income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 10495000000.00
MET balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 18543000000.00
MET balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 430000000.00
MET balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 430000000.00
MET income_statement (quarterly, 2025-06-30) — Normalized Income: 729000000.00
MET cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2187000000.00
MET income_statement (quarterly, 2025-06-30) — Operating Revenue: 17176000000.00
MET balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 666827962.00
MET balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 379000000.00
MET balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -19859000000.00
MET income_statement (quarterly, 2025-06-30) — Other Gand A: 130000000.00
MET income_statement (quarterly, 2025-06-30) — Other Income Expense: 75000000.00
MET income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 174000000.00
MET balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 90507000000.00
MET balance_sheet (quarterly, 2025-06-30) — Payables: 367000000.00
MET balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 367000000.00
MET income_statement (quarterly, 2025-06-30) — Policyholder Benefits Gross: 10495000000.00
MET balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 64032200.00
MET balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MET cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -31000000.00
MET income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 31000000.00
MET income_statement (quarterly, 2025-06-30) — Pretax Income: 980000000.00
MET cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -372000000.00
MET cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -21086000000.00
MET cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -273000000.00
MET balance_sheet (quarterly, 2025-06-30) — Receivables: 32718000000.00
MET cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -420000000.00
MET cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -510000000.00
MET balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 43447000000.00
MET income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1415000000.00
MET cash_flow (quarterly, 2025-06-30) — Sale Of Business: 203000000.00
MET cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 17517000000.00
MET cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 24000000.00
MET income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1545000000.00
MET balance_sheet (quarterly, 2025-06-30) — Share Issued: 1195301071.00
MET balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 27685000000.00
MET balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 18543000000.00
MET income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MET income_statement (quarterly, 2025-06-30) — Tax Provision: 245000000.00
MET income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
MET balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1215000000.00
MET balance_sheet (quarterly, 2025-06-30) — Total Assets: 702470000000.00
MET balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 47212000000.00
MET balance_sheet (quarterly, 2025-06-30) — Total Debt: 19906000000.00
MET balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 27927000000.00
MET income_statement (quarterly, 2025-06-30) — Total Expenses: 16196000000.00
MET balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 674543000000.00
MET balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 528473109.00
MET balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 29737000000.00
MET income_statement (quarterly, 2025-09-30) — +Total Revenue: 16881000000.00
MET balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 40329000000.00
MET balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 32855000000.00
MET income_statement (quarterly, 2025-09-30) — Basic Average Shares: 664700000.00
MET income_statement (quarterly, 2025-09-30) — Basic EPS: 1.23
MET cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 22178000000.00
MET balance_sheet (quarterly, 2025-09-30) — Capital Stock: 12000000.00
MET balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 20233000000.00
MET balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 114769000000.00
MET cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -444000000.00
MET cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -508000000.00
MET cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5018000000.00
MET cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1959000000.00
MET balance_sheet (quarterly, 2025-09-30) — Common Stock: 12000000.00
MET cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -378000000.00
MET balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 28944000000.00
MET cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -502000000.00
MET balance_sheet (quarterly, 2025-09-30) — Current Debt: 378000000.00
MET balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 378000000.00
MET income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 669100000.00
MET income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.22
MET income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 818000000.00
MET balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 369000000.00
MET income_statement (quarterly, 2025-09-30) — EBIT: 1481000000.00
MET cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 14000000.00
MET cash_flow (quarterly, 2025-09-30) — End Cash Position: 20233000000.00
MET cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -508000000.00
MET cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 3567000000.00
MET balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -17566000000.00
MET income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1529000000.00
MET balance_sheet (quarterly, 2025-09-30) — Goodwill: 9095000000.00
MET balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 9095000000.00
MET cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 308000000.00
MET income_statement (quarterly, 2025-09-30) — Interest Expense: 271000000.00
MET income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 271000000.00
MET cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 247000000.00
MET balance_sheet (quarterly, 2025-09-30) — Invested Capital: 48776000000.00
MET cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5018000000.00
MET balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 340714000000.00
MET balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 16349000000.00
MET cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 47000000.00
MET balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 19454000000.00
MET balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 19454000000.00
MET cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 47000000.00
MET cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -256000000.00